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Beginning in the 1970s, hypertension in children and adolescents has been
defined as systolic and/or diastolic blood pressure (BP) that is equal to or
greater than the 95th percentile of the normal BP distribution in healthy
children. The definition of hypertension in adults is based on longitudinal
data that links a BP level with an increased risk for subsequent adverse
outcomes related to hypertension including heart failure, kidney failure,
stroke, or death. The statistical definition of hypertension continues to be used
in childhood because there have been no data that link a BP level in childhood
with a heightened risk for adverse outcomes in adulthood. Findings from
clinical and epidemiologic research have advanced understanding of high
BP in childhood. While hypertension in some children can be secondary to
underlying kidney, cardiovascular, or endocrine disorder, it is now known that
primary (essential) hypertension can be present in childhood. The prevalence
of hypertension in childhood is approximately 2–5% and another 13–18% of
children and adolescents have elevated BP and are at heightened risk for
developing hypertension. The leading cause of childhood hypertension is
primary hypertension, especially in adolescents. For children and adolescents
with secondary hypertension, the treatment can focus on managing the
underlying cause of hypertension. Less is known about managing primary
hypertension in childhood, including diagnosis, evaluation, treatment, and
possibilities for prevention. The phenotype of primary hypertension in
childhood and recent findings will be discussed.
KEYWORDS

blood pressure, hypertension, children, adolescents, obesity

Introduction
Hypertension in adults is based on longitudinal data that defines a BP level that
increases the risk for subsequent adverse outcomes including heart failure, kidney
failure, stroke, or death. No such data have been available for children or adolescents.
In the 1970s, reference BP data became available on the normal distribution of
BP levels in children and adolescents according to age and sex (1, 2), and later,
height was added in the distribution (3). Based on that data, the definition of
hypertension in childhood became a systolic and/or diastolic BP ≥ 95th percentile
according to age, sex, and height. Therefore, unlike the outcome-based definition
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especially in early childhood and it was not known whether
a BP level at a given BP percentile consistently follows the
same percentile with growth. To determine whether BP
at a high BP percentile tracked from childhood through
adolescence, Chen and Wang (12) performed a systematic
review and meta-regression analysis that included 50 published
reports of longitudinal childhood studies that included BP
measurements in asymptomatic healthy children. Overall,
the tracking correlation coefficient varied considerably. With
further analysis, it was determined that the tracking coefficient
varied according to baseline age and length of follow-up.
For children <5 years at baseline measurement, the tracking
coefficient was insignificant at 0.18. However, by baseline age
8–9 years, the systolic BP tracking coefficient was significant
and consistent at 0.40–0.43 up to age 18 years. These findings
indicate that by mid-childhood, systolic BP levels at the higher
BP percentiles tend to track and indicate a heightened risk for
primary hypertension.

in adult hypertension, the pediatric definition of hypertension
in childhood has remained a statistical definition.
With available tables to identify abnormal BP in children
and adolescents, early pediatric guidelines on childhood
hypertension focused on diagnostic testing to identify a
secondary cause for the hypertension in a child or adolescent
including renal, cardiovascular, or endocrine disorder; and
primary (essential) hypertension was considered a disorder
limited to adulthood. The childhood obesity epidemic has
changed this perspective.

The primary hypertension
phenotype in childhood
An analysis of the two separate National Health and
Nutrition Survey (NHANES) periods in 2004 reported a
population increase in BP levels among children and adolescents
that was largely related to an increase in overweight/obesity
(4). A subsequent analysis of sequential NHANES periods
demonstrated that independent predictors of increasing BP
levels in children and adolescents were body mass index,
waist circumference, and dietary sodium intake (5). Clinical
reports on hypertensive adolescents noted a strong association
of obesity with hypertension (6). Other cross-sectional
clinical studies on adolescents with hypertension described a
strong association with obesity and also noted a substantial
prevalence of the left ventricular hypertrophy (LVH) in the
adolescents with hypertension (7–9). Based on these clinical
findings, the Fourth Report on childhood hypertension (10)
recommended an echocardiogram as part of the clinical
evaluation in hypertensive children to determine the presence
of hypertension-associated LVH as a measure of target organ
damage (TOD); screening for other risk factors including
lipids and glucose was also recommended. Subsequently,
dyslipidemia was also reported in children with obesityassociated hypertension (11). Therefore, it was becoming
apparent that childhood hypertension characterized by obesity
and cardiometabolic risk factors is a phenotype very similar to
primary hypertension in adults.

Blood pressure trajectories from
childhood to adulthood
Analysis of longitudinal data on BP and risk factors
associated with abnormal BP in prospective studies that began
in childhood and extended into early adulthood provide
a life-course perspective on childhood origins of primary
hypertension (13–15). Theodore et al. (13) analyzed data on
975 children who were enrolled at age 7 years and followed
with repeated measurements to age 38 years. At age 38 years,
participants were stratified based on BP status to hypertension,
pre-hypertension, high normal BP, and normotensive. Using
group-based trajectory modeling on BP curves for each BP
status group at age 38 years, there were four systolic BP
curves identified. According to BP classification at age 38 years,
there was a clear separation of the systolic BP trajectory
groups by 11 years of age. Significant risk factors identified
for the hypertensive and pre-hypertensive groups were low
birth weight, family history of hypertension, male sex, higher
body mass index (BMI), and cigarette smoking. BP trajectory
analysis was also performed by Hao et al. (14) in a cohort
of 546 participants enrolled in early childhood and followed
prospectively to adult age 30 years. Their data included
measures of the left ventricular mass index (LVMI) and carotid
intimal medial thickness (cIMT) as intermediate measures of
cardiovascular injury. The authors identified three separate
BP trajectory curves, designated as low-increasing, moderateincreasing, and high-increasing. By age 10 years, there was
a separation of the systolic BP trajectory curves. Systolic BP
was above 120 mmHg by age 15 years in the high-increasing
group. At age 30 years, LVMI and cIMT were highest in the
high-increasing systolic BP group. These reports demonstrate
that higher systolic BP levels in childhood can progress to

Blood pressure tracking in
childhood
Identifying primary hypertension in asymptomatic healthy
children and adolescents can be challenging. The BP reference
tables developed from cross-sectional data on BP measurements
in large samples of healthy children demonstrate a normal
progressive increase in BP level from early childhood through
adolescence consistent with normal childhood growth.
Clinically, it known that BP measurements tend to be variable,
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TOD in youth. The Study of Hypertension in Pediatrics, Adult
Hypertension Onset in Youth (Ship Ahoy) project was designed
to address this issue. Investigators sought to determine if the BP
threshold for LVH in youth was below the 95th percentile and
whether there were other cardiometabolic factors that raised
the risk for TOD in adolescents. Healthy adolescents, aged 11–
19 years, were enrolled, including participants with an average
BP level >95th, and stratified into three groups according to
office systolic BP measurements (average of six measurements
from two separate visits): low risk = BP < 80th percentile;
mid risk = 80th to <90th percentile; and high risk ≥ 90th
percentile. The groups were matched by age and demographics
with a slight difference in body mass index (BMI). Mean BP,
LVMI, and prevalence of LVH increased across groups: For
LVH, the low BP group prevalence = 13%, mid group = 21%,
and high group = 27%. Systolic BP percentile was found to
be a significant determinant of LVMI, and the 90th percentile
for systolic BP resulted in the best balance between sensitivity
and specificity in predicting LVH (LVMI > 38.8 gm/m2 .7 ).
These results demonstrate that abnormal cardiac mass can be
found at BP levels below the 95th percentile in adolescents (22).
Advancements in echocardiology enable the measurement of
cardiac function. In adults, cardiac function changes in left
ventricular strain and diastolic function are found to precede
decreases in left ventricular ejection fraction and CVD events.
Further analysis of echocardiographic data in the Ship Ahoy
cohort examined the effect of systolic BP level, across the three
BP groups, on left ventricular strain and diastolic function. The
mid-risk and high-risk participants had significantly lower left
ventricular ejection fraction and peak global longitudinal strain
than the low-risk group. The high-risk group had greater left
ventricular strain and lower diastolic function compared to
the mid-risk and low-risk groups. BP and adiposity were both
statistically significant determinants of impaired left ventricular
systolic and diastolic function (22). These novel findings
indicate that even subclinical changes in cardiac function can
be detected in adolescents with primary hypertension.
As noted above, increases in PWV, a measure of vascular
stiffness, are commonly associated with hypertension in adults.
Analysis of PWV data in the Ship Ahoy cohort was conducted
to determine whether BP-related increases in arterial stiffness
were present in adolescents with elevated BP. Carotid-femoral
PWV increased across the BP groups from low-risk group
to the high-risk groups. Aortic distensibility and compliance
were greater in the low-risk group than the mid-risk and
high-risk groups. Significant determinants of arterial stiffness
were sex, age, adiposity, BP, and low-density lipoprotein (LDL).
PWV and aortic compliance were significantly associated with
measures of TOD (systolic and diastolic cardiac function and
urine albumin/creatinine ratio) after controlling for BP level.
These results indicate that BP-related vascular stiffness can
also be detected at BP levels below the 95th percentile (23).
Moreover, in this analysis, low-density lipoprotein (LDL) level

hypertension and pre-hypertension by early adulthood with
markers of cardiovascular injury.
Subsequent analysis of data in longitudinal cohorts
examined associations of higher BP status in childhood with
intermediate markers of cardiovascular disease (CVD) in
adulthood, and Yang et al. (16) conducted a systematic review
of childhood to adulthood longitudinal cohort studies. The
meta-analysis determined that BP levels ≥90th percentile in
childhood or adolescence were significantly associated with risk
for LVH, with a pooled odds ratio (OR) 1.40 (95% CI = 1.20–
1.64); vascular stiffness ascertained by pulse wave velocity
(PWV) OR 1.83 (95% CI = 1.39–2.40); and high cIMT, OR 1.60
(95% CI = 1.29–2.00). This systematic review also identified
some associations of abnormal BP in adolescence with clinical
CVD and mortality in adulthood. More recently, investigators
in the International Childhood Cardiovascular Cohorts (i3C)
Consortium reported an analysis on longitudinal data in the
childhood to adulthood cohorts to determine whether there
was an association of risk factors in childhood with CVD events
in adulthood. Childhood risk factors considered were systolic
BP, BMI, total cholesterol level, triglyceride level, and youth
smoking. For each risk factor, age- and sex-specific z-scores
were determined and a combined-risk z-score was calculated.
There were 319 fatal cardiovascular events among 38,589
participants. The hazard ratio for the combined-risk z-score
was 2.71 (95% CL, 2.23 to 3.29) per unit increase. A similar
finding was found in the analysis of 779 fatal and non-fatal
cardiovascular events that occurred in 20,656 participants (17).
The results in this publication provide evidence that high BP
and other cardiovascular risk factors in childhood are associated
with adverse CVD outcomes in mid-adulthood.

Markers of cardiovascular injury in
youth
The above describes associations of abnormal BP in
youth with intermediate markers of cardiovascular disease,
commonly termed target organ damage (TOD), in early
adulthood. Moreover, LVH is frequently found in adolescents
with confirmed primary hypertension, having systolic BP
consistently ≥95th percentile (7–9). In adolescents with
hypertension, confirmed by ambulatory blood pressure
monitoring, subclinical, alterations in cognitive function
have also been demonstrated. Compared to normotensive
adolescents, adolescents with hypertension had scores
significantly lower on tests of memory, attention, and executive
function (18, 19).
Additional clinical studies also reported LVH in
overweight/obese adolescents with pre-hypertension and
hypertension (20, 21). These reports found that elevated BP
and obesity were both independently associated with LVH in
youth and led to questions on what BP level was linked with
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but documentation of diagnosis and appropriate follow-up
remains sub-optimal. A necessary step in identifying and
managing abnormal BP is the accurate measurement of BP.
A flawed technique used in the measurement of BP in both
children and adults results in inaccurate readings. Staff who
measure BP in children and adolescents in a primary care setting
should be trained in a standard BP measurement protocol (27,
28, 36). It is also important to use a BP monitor that is validated
for accuracy in children (37, 38).
Strategies and tools are still needed to help primary care
clinicians overcome the barriers to appropriate screening,
recognition, and confirming abnormal BP in children and
adolescents (39). This is especially important because the rates
of childhood obesity, the major risk factor for pediatric primary
hypertension, are increasing (40). Moreover, an analysis of data
in the prospective cohort Coronary Artery Risk Development
in Young Adults (CARDIA) study found that young adults,
with stage 1, stage 2 hypertension, and even elevated BP, had a
significantly higher risk for subsequent CVD events compared
to those who had normal BP before age 40 years (41). With
the increasing prevalence of hypertension in adolescents, it is
expected that the prevalence in young adults will also increase.
In the United States, CVD projections estimate significant
increases in CVD among adults in future decades, including
hypertension (42). Detection and effective management of
hypertension and elevated BP in adolescence, as well as
primordial prevention beginning in early childhood, would
have a substantial impact on stemming the rising tide of
CVD in adults. Adolescents should be able to enter adulthood
with a normal BP.

was significantly associated with vascular stiffness. The Ship
Ahoy investigators conducted additional analysis to determine
whether there is a metabolic phenotype associated with TOD in
adolescents with elevated BP or hypertension. A cardiovascular
disease risk score was developed using the number of CVD risk
conditions including hypertension, dyslipidemia, obesity, and
insulin resistance present in each participant. Generalized linear
models indicated that dyslipidemia and insulin resistance were
independently associated with markers of diastolic dysfunction,
and increased systolic BP was associated with all markers of
TOD (24). These publications from the Ship Ahoy project
describe a high-risk phenotype in adolescence for subsequent
cardiovascular disease that includes evidence of TOD as well as
multiple risk factors even at BP levels below the 95th percentile.

Prevalence and diagnosis of
primary hypertension in childhood
Reports on the prevalence of primary hypertension in
childhood vary based on the population studied, location of
the population, how the BP is measured, the number of
BP measurements, the definition of hypertension, and the
reference data on normative BP levels for age and sex. The
overall estimated prevalence of hypertension in childhood is
approximately 2–5% and the prevalence of elevated BP is
13–18% (25, 26), with higher rates in adolescence compared
to childhood. The prevalence of secondary hypertension is
approximately 1% and is generally identified in early childhood
or in children with markedly elevated BP (27, 28). It is now
established that primary hypertension is the most common type
of hypertension in the young, especially in adolescence.
Some children are at greater risk for primary hypertension
including children with overweight or obesity and children
with a history of low birthweight. A sub-optimal diet can be a
target for intervention in childhood and adulthood. Dietary salt
intake is high in childhood with most children and adolescents
exceeding recommended limits in sodium intake, largely due to
the consumption of processed foods (29).
In clinical practice, it is challenging to recognize abnormal
BP levels in asymptomatic otherwise healthy children and
adolescents. Although BP measurement in children, beginning
at age 3 years, is now standard practice in primary care settings,
examinations of electronic health records have demonstrated
under-recognition and underdiagnosis of hypertension in
children and adolescents (30, 31). Evidence-based guidelines
are available to facilitate diagnosis, evaluation, and management
of hypertension including both primary and secondary
hypertension (27, 28, 32). However, recognizing abnormal BP
levels and taking appropriate steps in follow-up continue to
be difficult to achieve in primary care settings (33). Electronic
medical record alerts (34) and clinical decision support systems
(35) improve recognition of abnormal BP in children somewhat
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